| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Hopfield Jessica is a Director at MRVI, with reported holdings spanning 3 companies. Recent filings cover 7 purchases and 2 sales. Those positions are worth an estimated $814K at current prices.
Our model assigns Hopfield Jessica a below-average insider score of 31/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -23.2%.
Hopfield Jessica's largest disclosed position is in MRVI as Director, worth about $432K. Net of sales, the recent Form 4 record there shows accumulation of 50,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2025 | PODD Insulet Corp | Director | Sale+OE | 5,235 | $317.54 | $1,662,321.90 | -16.3% | -3.1% | -52.7% | |
| Sep 11, 2024 | PODD Insulet Corp | Director | Sale+OE | 7,628 | $225.26 | $1,718,283.28 | -22.1% | +20.7% | +48.4% | |
| May 13, 2024 | EDIT Editas Medicine, Inc. | Director | Buy | 45,000 | $5.64 | $253,867.50 | +198.2% | -31.3% | -73.7% | |
| Mar 3, 2021 | EDIT Editas Medicine, Inc. | Director | Buy | 5,800 | $45.51 | $263,969.60 | +34.3% | - | - | |
| Nov 24, 2020 | MRVI Maravai Lifesciences Holdings, Inc. | Director | Buy | 50,000 | $27.00 | $1,350,000.00 | +421.9% | - | - | |
| Mar 5, 2019 | EDIT Editas Medicine, Inc. | Director | Buy | 10,200 | $23.94 | $244,188.00 | +152.2% | - | - | |
| May 17, 2018 | EDIT Editas Medicine, Inc. | Director | Buy | 6,700 | $37.28 | $249,780.02 | New | - | - | |
| May 11, 2017 | PODD Insulet Corp | Director | Buy | 2,580 | $38.68 | $99,782.53 | +20.4% | - | - | |
| Mar 2, 2016 | PODD Insulet Corp | Director | Buy | 3,230 | $30.91 | $99,839.30 | +57.6% | - | - |